Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Ophthalmology Drugs Market Analysis 2016 - Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 03 Oct 16

Research and Markets has announced the addition of the "Global Ophthalmology Drugs Market Analysis 2016 - Forecast to 2022" report to their offering.

This report analyzes the global markets for Ophthalmology Drugs. The market assessment is performed through standard and the tailored research methodology approach.

The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments.

Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Ophthalmology Drugs Market by Delivery Type

5.1 Introduction

5.2 Eye drops

5.3 Eye Solutions

5.4 Capsules & Tablets

5.5 Eye ointment

5.6 Gels

6 Ophthalmology Drugs Market by Treatment

6.1 Introduction

6.2 Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs

6.3 Dry eye drugs

6.4 Anti-glaucoma drugs

6.5 Retinal disorders

7 Geographical Segmentation

8 Vendor Landscaping

9 Company Profiles

9.1 Pfizer Inc

9.2 Hoya Corporation

9.3 Bayer

9.4 Novartis International AG

9.5 Abbott Medical Optics, Inc.

9.6 Ziemer Ophthalmic Systems AG

9.7 Regeneron

9.8 Johnson & Johnson Vision Care, Inc.

9.9 Bausch & Lomb Inc.

9.10 Topcon Corporation

9.11 Ellex Medical Lasers Ltd.

9.12 Alcon Inc.

9.13 Merck & Co., Inc

9.14 Spark Therapeutics

9.15 Insight Vision Inc.

9.16 Roche Holding Ltd

9.17 Ophthotech

9.18 Novagali Pharma S A

9.19 Allergan, Inc.

9.20 Carl-Zeiss AG

9.21 Santen

9.22 Essilor International S.A.

For more information about this report visit

View source version on

Business Wire

Last updated on: 03/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.